Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
AMETEK Inc ha un obiettivo di prezzo di consenso pari a $202.93, stabilito in base alle ultime valutazioni degli analisti di 16. Le ultime 3 valutazioni degli analisti sono state rilasciate da Truist Securities, Barclays y TD Cowen il octubre 8, 2025, septiembre 10, 2025 y septiembre 2, 2025. Con un obiettivo di prezzo medio di $203 tra le Truist Securities, Barclays y TD Cowen, c'è un implicito 9.73% upside per AMETEK Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
10/08/2025 | 23.78% | Truist Securities | $219 → $229 | Maintains | Buy | |||
09/10/2025 | 8.11% | Barclays | → $200 | Initiates | → Equal-Weight | |||
09/02/2025 | -2.7% | TD Cowen | $158 → $180 | Upgrade | Sell → Hold | |||
08/08/2025 | 7.03% | Morgan Stanley | $185 → $198 | Maintains | Equal-Weight | |||
08/04/2025 | 7.03% | Baird | $190 → $198 | Maintains | Neutral | |||
08/01/2025 | 16.22% | DA Davidson | $210 → $215 | Maintains | Buy | |||
08/01/2025 | 21.62% | Mizuho | $212 → $225 | Maintains | Outperform | |||
08/01/2025 | 14.59% | RBC Capital | $209 → $212 | Maintains | Outperform | |||
08/01/2025 | 10.81% | Keybanc | $195 → $205 | Maintains | Overweight | |||
05/16/2025 | 12.97% | RBC Capital | $201 → $209 | Maintains | Outperform | |||
05/07/2025 | 2.7% | Baird | $197 → $190 | Maintains | Neutral | |||
05/05/2025 | 8.11% | Truist Securities | $196 → $200 | Maintains | Buy | |||
05/02/2025 | 8.65% | RBC Capital | $194 → $201 | Maintains | Outperform | |||
04/14/2025 | -8.11% | Morgan Stanley | → $170 | Initiates | → Equal-Weight | |||
04/08/2025 | 5.95% | Truist Securities | $216 → $196 | Maintains | Buy | |||
02/05/2025 | 10.27% | RBC Capital | $210 → $204 | Maintains | Outperform | |||
02/05/2025 | 6.49% | Baird | $200 → $197 | Maintains | Neutral | |||
01/16/2025 | 20% | Truist Securities | $221 → $222 | Maintains | Buy | |||
12/16/2024 | 21.62% | B of A Securities | $195 → $225 | Upgrade | Neutral → Buy | |||
11/22/2024 | 16.22% | Keybanc | $205 → $215 | Maintains | Overweight | |||
11/04/2024 | 0.54% | Baird | $166 → $186 | Maintains | Neutral | |||
11/01/2024 | 8.11% | Mizuho | $190 → $200 | Maintains | Outperform | |||
11/01/2024 | 19.46% | Truist Securities | $219 → $221 | Maintains | Buy | |||
10/17/2024 | 2.7% | Mizuho | $180 → $190 | Maintains | Outperform | |||
10/09/2024 | 18.38% | Truist Securities | $201 → $219 | Maintains | Buy | |||
10/07/2024 | — | TD Cowen | — | Downgrade | Hold → Sell | |||
08/07/2024 | -10.27% | Baird | $171 → $166 | Maintains | Neutral | |||
08/05/2024 | -14.59% | TD Cowen | $165 → $158 | Maintains | Hold | |||
08/02/2024 | 16.22% | RBC Capital | $216 → $215 | Maintains | Outperform | |||
08/02/2024 | 8.65% | Truist Securities | $204 → $201 | Maintains | Buy | |||
07/02/2024 | 10.27% | Truist Securities | $210 → $204 | Maintains | Buy | |||
05/22/2024 | 8.11% | Oppenheimer | → $200 | Upgrade | Perform → Outperform | |||
05/06/2024 | -7.57% | Baird | $173 → $171 | Maintains | Neutral | |||
03/14/2024 | 13.51% | Truist Securities | → $210 | Initiates | → Buy | |||
02/27/2024 | 10.81% | Keybanc | $182 → $205 | Maintains | Overweight | |||
02/07/2024 | 1.62% | RBC Capital | $192 → $188 | Maintains | Outperform | |||
02/07/2024 | -1.62% | Keybanc | $176 → $182 | Maintains | Overweight | |||
11/27/2023 | -13.51% | TD Cowen | $165 → $160 | Downgrade | Outperform → Market Perform | |||
11/01/2023 | 0.54% | RBC Capital | $183 → $186 | Maintains | Outperform | |||
09/21/2023 | -1.62% | RBC Capital | $182 → $182 | Reiterates | Outperform → Outperform | |||
08/07/2023 | 5.41% | Seaport Global | → $195 | Initiates | → Buy | |||
08/02/2023 | -1.62% | RBC Capital | $174 → $182 | Maintains | Outperform | |||
08/02/2023 | -5.95% | Morgan Stanley | $162 → $174 | Maintains | Overweight | |||
08/02/2023 | -10.27% | Mizuho | $161 → $166 | Maintains | Buy | |||
08/02/2023 | — | Wells Fargo | $180 → $185 | Maintains | Overweight | |||
08/02/2023 | -4.86% | Keybanc | $165 → $176 | Maintains | Overweight | |||
07/12/2023 | -12.43% | Morgan Stanley | $159 → $162 | Maintains | Overweight | |||
06/08/2023 | -2.7% | DA Davidson | $177 → $180 | Maintains | Buy | |||
05/04/2023 | -14.05% | Morgan Stanley | $155 → $159 | Maintains | Overweight | |||
05/03/2023 | -10.81% | RBC Capital | $165 → $165 | Reiterates | Outperform → Outperform | |||
05/03/2023 | -12.97% | Mizuho | $153 → $161 | Maintains | Buy | |||
02/23/2023 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
02/03/2023 | -16.22% | Morgan Stanley | $152 → $155 | Maintains | Overweight | |||
01/13/2023 | -17.3% | Mizuho | $145 → $153 | Maintains | Buy | |||
01/06/2023 | -17.84% | Morgan Stanley | $144 → $152 | Maintains | Overweight | |||
11/21/2022 | -10.81% | Keybanc | $145 → $165 | Maintains | Overweight | |||
11/02/2022 | -26.49% | RBC Capital | $135 → $136 | Maintains | Outperform | |||
11/02/2022 | -21.62% | Mizuho | $140 → $145 | Maintains | Buy | |||
11/02/2022 | -22.16% | Morgan Stanley | $137 → $144 | Maintains | Overweight | |||
10/24/2022 | -10.81% | Wells Fargo | $180 → $165 | Maintains | Overweight |
El último precio objetivo de AMETEK (NYSE:AME) fue comunicado por Truist Securities el octubre 8, 2025. La firma de analistas fijó un precio objetivo para $229.00 que espera AME a rise dentro de 12 meses (un posible 23.78% upside). 23 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para AMETEK (NYSE:AME) fue proporcionada por Truist Securities, y AMETEK mantuvo su buy calificación.
La última revisión al alza de AMETEK Inc se produjo en septiembre 2, 2025, cuando TD Cowen elevó su precio objetivo a $180. TD Cowen anteriormente tenía a sell para AMETEK Inc.
La última revisión a la baja de AMETEK Inc se produjo en octubre 7, 2024, cuando TD Cowen cambió su precio objetivo de N/A a N/A para AMETEK Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de AMETEK, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de AMETEK se registró el octubre 8, 2025, por lo que la próxima calificación estará disponible en torno al octubre 8, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de AMETEK (AME) fue un mantuvo con un precio objetivo de $219.00 a $229.00. El precio actual al que cotiza AMETEK (AME) es de $185.00, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.